Webinars

Hypercoagulable State Associated with COVID-19 Infection

Presentation

Chapters

Video

About this Webinar

Date: Thursday, November 12, 2020

Author: Racke, Frederick K., MD, PhD.
Medical Director, Hematology/Oncology and Coagulation,
Nichols Institute
Quest Diagnostics
San Juan Capistrano, CA
  
Also by this Author ▸

Author: Wong, Edward C. C., MD
Medical Director, Quest Diagnostics; Adj Assoc Professor, George Washington School of Medicine and Health Sciences; Clinical Consultant, Children’s National Hospital  
Also by this Author ▸

Category: Webinar

Description: • Identify key coagulation markers that are associated with increased mortality in COVID-19 infected patients
• Distinguish COVID-19 hypercoagulability from other hypercoagulable states
• Understand key laboratory issues associated with thrombophilia testing and anticoagulant monitoring in patients with COVID-19 infection

Related Content

Presentation:
Addressing a public health crisis: applications for COVID-19 antibody testing
Kapoor, Hema, MD, D (ABMM), SM Meyer III, William A., PhD, D(ABMM), MLS(ASCP)CM Wohlgemuth, Jay G., M.D.

Presentation:
Latest Developments in COVID-19 Testing: An Update for Community Health Centers
Wohlgemuth, Jay G., M.D.

Presentation:
Testing for COVID-19: what you need to know – June 24 update
Wohlgemuth, Jay G., M.D.